Fabio V. Teixeira

Marilia, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.

Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.

Journal: BMC gastroenterology

Published: October 17, 2024

ARE WE READY FOR MULTIPLE SWITCHES BETWEEN REFERENCE PRODUCTS AND BIOSIMILARS?

ARE WE READY FOR MULTIPLE SWITCHES BETWEEN REFERENCE PRODUCTS AND BIOSIMILARS?

Journal: Arquivos de gastroenterologia

Published: April 26, 2024

Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.

Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.

Journal: Crohn's & colitis 360

Published: January 14, 2024

Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American Study.

Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American Study.

Journal: Pharmaceutics

Published: December 30, 2022

Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study.

Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study.

Journal: Crohn's & colitis 360

Published: September 14, 2022

"A case of vanishing bone disease complicated by chylothorax- diagnosis and treatment".

"A case of vanishing bone disease complicated by chylothorax- diagnosis and treatment".

Journal: JRSM open

Published: July 01, 2022

Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).

Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).

Journal: BMC gastroenterology

Published: November 04, 2021

Perception and clinical decisions from inflammatory bowel diseases' specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB).

Perception and clinical decisions from inflammatory bowel diseases' specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB).

Journal: Gastroenterologia y hepatologia

Published: July 07, 2021

International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.

International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.

Journal: Nature reviews. Gastroenterology & hepatology

Published: July 05, 2021

Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients.

Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients.

Journal: Therapeutic advances in gastroenterology

Published: February 05, 2021

BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.

BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.

Journal: Arquivos de gastroenterologia

Published: January 12, 2021

Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review.

Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review.

Journal: Journal of clinical medicine

Published: December 30, 2020

Showing 1-12 of 38

Last Updated: 09/26/2026